FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for ALBUTEROL SULFATE submitted by Padagis Israel Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchospasm
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Albuterol sulfate (Albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE (ALBUTEROL SULFATE)